Apligaf Scheibe mit 75 mm Durchmesser (G100)

Apligaf Scheibe mit 75 mm Durchmesser (G100) is a medicine authorised by Swissmedic under authorisation number 58943. The authorisation holder is Organogenesis Switzerland GmbH. The medicinal product code is Transplantat: Gewebeprodukt and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 16 April 2015 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.

  • Dispensing category A
  • Authorisation number 58943
  • Transplantat: Gewebeprodukt
Authorisation data
Authorisation number58943
NameApligaf Scheibe mit 75 mm Durchmesser (G100)
Full nameApligaf Scheibe mit 75 mm Durchmesser (G100)
Authorisation holderOrganogenesis Switzerland GmbH
Medicinal product codeTransplantat: Gewebeprodukt
Dispensing categoryA · Prescription, not repeatable
ATC codenot stated
First authorisation16 April 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Apligaf Scheibe mit 75 mm Durchmesser (G100)A16 April 2015
2Apligaf Scheibe mit 24 mm Durchmesser (G10)A31 August 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
175 mmScheibe(n)/disque(s)-10.06.0.A
224 mmScheibe(n)/disque(s)-10.06.0.A

Scroll the table sideways

Frequently asked questions

Is Apligaf Scheibe mit 75 mm Durchmesser (G100) authorised in Switzerland?

Yes. Apligaf Scheibe mit 75 mm Durchmesser (G100) is authorised by Swissmedic under authorisation number 58943, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Apligaf Scheibe mit 75 mm Durchmesser (G100) have?

Apligaf Scheibe mit 75 mm Durchmesser (G100) is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Apligaf Scheibe mit 75 mm Durchmesser (G100)?

The authorisation holder is Organogenesis Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com